Teizo Asano

7PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Sensor technology (incl. chemical aspects)Flow analysisPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 25, 2023
Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C44Mab-9 for Multiple Applications against Colorectal Carcinomas.

Ryo Ejima, Hiroyuki Suzuki, Tomohiro Tanaka

|Dec 22, 2022
Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies Using Flow Cytometry.

Nami Tateyama, Teizo Asano, Hiroyuki Suzuki

|Dec 22, 2022
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG2a-f) Exerts Antitumor Activity in Xenograft Model.

Teizo Asano, Tomohiro Tanaka, Hiroyuki Suzuki

|Nov 26, 2022
Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma.

Nami Tateyama, Hiroyuki Suzuki, Tomokazu Ohishi

|Jun 23, 2022
Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications.

Guanjie Li, Hiroyuki Suzuki, Teizo Asano

Pageof 2